These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27076296)

  • 1. Towards a Preventive Strategy for Toxoplasmosis: Current Trends, Challenges, and Future Perspectives for Vaccine Development.
    Fereig RM; Nishikawa Y
    Methods Mol Biol; 2016; 1404():153-164. PubMed ID: 27076296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxoplasma gondii: Vaccination with a DNA vaccine encoding T- and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice.
    Cao A; Liu Y; Wang J; Li X; Wang S; Zhao Q; Cong H; He S; Zhou H
    Vaccine; 2015 Nov; 33(48):6757-62. PubMed ID: 26518401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Toxoplasma gondii vaccine encoding multistage antigens in conjunction with ubiquitin confers protective immunity to BALB/c mice against parasite infection.
    Yin H; Zhao L; Wang T; Zhou H; He S; Cong H
    Parasit Vectors; 2015 Sep; 8():498. PubMed ID: 26420606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.
    Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H
    Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective efficacy induced by DNA prime and recombinant protein boost vaccination with Toxoplasma gondii GRA14 in mice.
    Pagheh AS; Sarvi S; Gholami S; Asgarian-Omran H; Valadan R; Hassannia H; Ahmadpour E; Fasihi-Ramandie M; Dodangeh S; Hosseni-Khah Z; Daryani A
    Microb Pathog; 2019 Sep; 134():103601. PubMed ID: 31212035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of immunogenicity and protective effect of DNA vaccine encoding surface antigen1 (SAG1) of Toxoplasma gondii and TLR-5 ligand as a genetic adjuvant against acute toxoplasmosis in BALB/c mice.
    Maraghi S; Ghadiri AA; Tavalla M; Shojaee S; Abdizadeh R
    Biologicals; 2019 Nov; 62():39-49. PubMed ID: 31610951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in developing vaccines against Toxoplasma gondii: an update.
    Zhang NZ; Wang M; Xu Y; Petersen E; Zhu XQ
    Expert Rev Vaccines; 2015; 14(12):1609-21. PubMed ID: 26467840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moving towards improved vaccines for Toxoplasma gondii.
    Li Y; Zhou H
    Expert Opin Biol Ther; 2018 Mar; 18(3):273-280. PubMed ID: 29216783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice.
    Zheng B; Lu S; Tong Q; Kong Q; Lou D
    Vaccine; 2013 Sep; 31(41):4578-84. PubMed ID: 23928460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological evaluation of a DNA cocktail vaccine with co-delivery of calcium phosphate nanoparticles (CaPNs) against the Toxoplasma gondii RH strain in BALB/c mice.
    Rahimi MT; Sarvi S; Sharif M; Abediankenari S; Ahmadpour E; Valadan R; Ramandie MF; Hosseini SA; Daryani A
    Parasitol Res; 2017 Feb; 116(2):609-616. PubMed ID: 27909791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response and protective effect against chronic Toxoplasma gondii infection induced by vaccination with a DNA vaccine encoding profilin.
    Gao Q; Zhang NZ; Zhang FK; Wang M; Hu LY; Zhu XQ
    BMC Infect Dis; 2018 Mar; 18(1):117. PubMed ID: 29514647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxoplasma gondii: protective effect of an intranasal SAG1 and MIC4 DNA vaccine in mice.
    Wang H; He S; Yao Y; Cong H; Zhao H; Li T; Zhu XQ
    Exp Parasitol; 2009 Jul; 122(3):226-32. PubMed ID: 19366622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MVA ROP2 vaccinia virus recombinant as a vaccine candidate for toxoplasmosis.
    Roque-Reséndiz JL; Rosales R; Herion P
    Parasitology; 2004 Apr; 128(Pt 4):397-405. PubMed ID: 15151145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice.
    Qu D; Wang S; Cai W; Du A
    Vaccine; 2008 Aug; 26(35):4541-8. PubMed ID: 18590785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of protective immunity induced by DNA vaccination with genes encoding Toxoplasma gondii GRA17 and GRA23 against acute toxoplasmosis in mice.
    Zhu WN; Wang JL; Chen K; Yue DM; Zhang XX; Huang SY; Zhu XQ
    Exp Parasitol; 2017 Aug; 179():20-27. PubMed ID: 28625894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of the protective efficacy of a ROP18 vaccine against chronic toxoplasmosis by nasal route.
    Rashid I; Moiré N; Héraut B; Dimier-Poisson I; Mévélec MN
    Med Microbiol Immunol; 2017 Feb; 206(1):53-62. PubMed ID: 27757545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination as a control strategy against the coccidial parasites Eimeria, Toxoplasma and Neospora.
    Innes EA; Vermeulen AN
    Parasitology; 2006; 133 Suppl():S145-68. PubMed ID: 17274844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with toxofilin DNA in combination with an alum-monophosphoryl lipid A mixed adjuvant induces significant protective immunity against Toxoplasma gondii.
    Song P; He S; Zhou A; Lv G; Guo J; Zhou J; Han Y; Zhou H; Hao Z; Cong H
    BMC Infect Dis; 2017 Jan; 17(1):19. PubMed ID: 28056837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with recombinant Toxoplasma gondii CDPK3 induces protective immunity against experimental toxoplasmosis.
    Wu M; An R; Chen Y; Chen T; Wen H; Yan Q; Shen J; Chen L; Du J
    Acta Trop; 2019 Nov; 199():105148. PubMed ID: 31425673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Live Attenuated Pru:Δcdpk2 Strain of Toxoplasma gondii Protects Against Acute, Chronic, and Congenital Toxoplasmosis.
    Wang JL; Li TT; Elsheikha HM; Chen K; Cong W; Yang WB; Bai MJ; Huang SY; Zhu XQ
    J Infect Dis; 2018 Jul; 218(5):768-777. PubMed ID: 29669003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.